Chemical Relaxer Hair Damage —
When Hair Transplant Can Help

How chemical relaxers damage hair and follicles

Chemical relaxers (lye and no-lye relaxers) work by breaking the disulfide bonds in the hair shaft, permanently straightening the curl. Applied correctly at appropriate intervals, relaxers primarily affect the hair shaft — not the follicle. But misapplication, overprocessing, scalp burns or the combination of relaxers with other chemical or mechanical stress can damage follicles permanently.

The most common patterns of permanent relaxer-related hair loss are: diffuse thinning from repeated chemical trauma to miniaturised follicles; scarring at the scalp where chemical burns have occurred; and combined CCCA progression accelerated by relaxer use.

What is reversible and what is permanent

The majority of relaxer-related hair changes — shaft weakness, breakage, dryness — are not permanent hair loss. They affect the existing hair strand but leave the follicle intact. Discontinuing relaxers and implementing a protein and moisture recovery regime typically restores hair health within 6–18 months.

Permanent loss occurs when the follicle itself is damaged — through scalp burns, severe chemical trauma, or the inflammatory scarring process of CCCA. In these cases, the follicle cannot recover regardless of what products are applied.

When hair transplant helps

Hair transplant is appropriate for relaxer-related hair loss when: trichoscopy confirms permanent follicle loss in specific zones, the overall hair loss pattern is stable, and the donor area is unaffected. This typically applies to women with scalp scarring from chemical burns, women with permanent hairline recession from combined relaxer and traction damage, and women with CCCA that has been accelerated by chemical processing.

Dr. Arslan's assessment for chemical damage cases

Dr. Arslan's assessment for patients with relaxer-related hair loss includes trichoscopy to distinguish permanent follicle loss from shaft damage and temporary shedding, scalp examination for evidence of scarring or ongoing inflammation, and an honest discussion about whether medical management, surgery, or a combination is the appropriate approach. Many patients who present for surgery are better served by a dermatological treatment protocol first — and Dr. Arslan will recommend this when appropriate.

Common questions

Related articles

References & sources

1. 1.Akintilo L et al. Managing traction alopecia in Black women. Dermatology Advisor / UC Davis Medical Center. 2024. https://www.dermatologyadvisor.com/features/managing-traction-alopecia-black-women/
2. 2.Haskin A, Aguh C. All hairstyles are not created equal: what the dermatologist needs to know about Black hairstyling practices and the risk for traction alopecia. Journal of the American Academy of Dermatology. 2016. https://doi.org/10.1016/j.jaad.2016.02.1162
3. 3.MedlinePlus NIH. Traction alopecia — clinical overview. U.S. National Library of Medicine. 2024. https://medlineplus.gov/ency/article/001470.htm
4. 4.Kyei A et al. Hair transplantation in CCCA in African American women. PubMed. 2014. https://pubmed.ncbi.nlm.nih.gov/25207763/
5. 5.Callender VD, McMichael AJ. Central centrifugal cicatricial alopecia: clinical presentation, pathology and management. Dermatologic Therapy. 2004. https://doi.org/10.1111/j.1396-0296.2004.04032.x

All references are peer-reviewed medical literature or official health authority publications. No commercial sources included.